GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
25 Sep 2014 01:11 PM
RNS
Director/PDMR Shareholding
25 Sep 2014 01:08 PM
RNS
Director/PDMR Shareholding
25 Sep 2014 08:00 AM
RNS
Directorate Change
19 Sep 2014 09:06 AM
RNS
GSK China Investigation Outcome
16 Sep 2014 08:50 AM
RNS
Director/PDMR Shareholding
10 Sep 2014 04:43 PM
RNS
Director/PDMR Shareholding
08 Sep 2014 01:45 PM
RNS
Publication positive study results mepolizumab
03 Sep 2014 01:22 PM
RNS
Triumeq receives EU approval
02 Sep 2014 03:50 PM
RNS
Director/PDMR Shareholding
01 Sep 2014 03:26 PM
RNS
Total Voting Rights
26 Aug 2014 07:19 AM
RNS
Triumeq US Approval
22 Aug 2014 11:06 AM
RNS
Director/PDMR Shareholding
18 Aug 2014 04:21 PM
RNS
Director/PDMR Shareholding
12 Aug 2014 04:50 PM
RNS
Director/PDMR Shareholding
11 Aug 2014 04:27 PM
RNS
Director/PDMR Shareholding
08 Aug 2014 04:10 PM
RNS
Director/PDMR Shareholding
08 Aug 2014 04:07 PM
RNS
Director/PDMR Shareholding
05 Aug 2014 10:37 AM
RNS
Director/PDMR Shareholding
04 Aug 2014 01:28 PM
RNS
Publication of Prospectus
01 Aug 2014 12:19 PM
RNS
Total Voting Rights
24 Jul 2014 05:47 PM
RNS
Director/PDMR Shareholding
24 Jul 2014 08:32 AM
RNS
Blocklisting Interim Review
23 Jul 2014 12:00 PM
RNS
Half Yearly Report
21 Jul 2014 05:47 PM
RNS
Director/PDMR Shareholding
21 Jul 2014 05:45 PM
RNS
Director/PDMR Shareholding
21 Jul 2014 05:44 PM
RNS
Director/PDMR Shareholding
21 Jul 2014 05:38 PM
RNS
Director/PDMR Shareholding
18 Jul 2014 04:27 PM
RNS
Director/PDMR Shareholding
18 Jul 2014 04:25 PM
RNS
Director/PDMR Shareholding
18 Jul 2014 04:24 PM
RNS
Director/PDMR Shareholding
17 Jul 2014 02:00 PM
RNS
MEK/BRAF combination phase III study update
16 Jul 2014 04:59 PM
RNS
Director/PDMR Shareholding
16 Jul 2014 07:00 AM
RNS
Start of phase III study - FF/UMEC/VI combination
14 Jul 2014 04:11 PM
RNS
Director/PDMR Shareholding
14 Jul 2014 04:11 PM
RNS
Director/PDMR Shareholding
11 Jul 2014 05:07 PM
RNS
Director/PDMR Shareholding
11 Jul 2014 05:05 PM
RNS
Director/PDMR Shareholding
11 Jul 2014 05:03 PM
RNS
Director/PDMR Shareholding
10 Jul 2014 04:37 PM
RNS
Director/PDMR Shareholding
10 Jul 2014 04:23 PM
RNS
Director/PDMR Shareholding
10 Jul 2014 04:18 PM
RNS
Director/PDMR Shareholding
08 Jul 2014 03:57 PM
RNS
Director/PDMR Shareholding
07 Jul 2014 05:00 PM
RNS
Director/PDMR Shareholding
02 Jul 2014 03:11 PM
RNS
Director/PDMR Shareholding
01 Jul 2014 10:53 AM
RNS
Total Voting Rights
30 Jun 2014 05:17 PM
RNS
Director/PDMR Shareholding
30 Jun 2014 01:00 PM
RNS
Breo Ellipta US regulatory submission
27 Jun 2014 12:42 PM
RNS
Triumeq receives positive CHMP opinion
24 Jun 2014 05:30 PM
RNS
Transaction in Own Shares
23 Jun 2014 05:14 PM
RNS
Director/PDMR Shareholding

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings